Benzocaine Gel

If you find any inaccurate information, please let us know by providing your feedback here

Benzocaine Gel

Ước tính: 1 phút đọc, Ngày đăng:

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition

Issued and maintained by the United States Pharmacopeial Convention (USP)

DOWNLOAD PDF HERE

1 DEFINITION

Benzocaine Gel contains NLT 90.0% and NMT 110.0% of the labeled amount of benzocaine (C9H11NO2).

2 IDENTIFICATION

A. The UV spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.

B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.

3 ASSAY

3.1 PROCEDURE

Solution A: 0.1% Trifluoroacetic acid, prepared by diluting 1.0 mL of trifluoroacetic acid with water to 1 L

Solution B: Acetonitrile

Mobile phase: See Table 1.

Table 1

Time (min)Solution A (%)Solution B (%)
09010
345050
359010
389010

Diluent: Solution A and Solution B (1:1)

System suitability solution: 1 µg/mL of USP Benzocaine RS and 2 µg/mL each of USP Aminobenzoic Acid RS and USP Ethyl 4-nitrobenzoate RS in Diluent

Standard solution: 0.1 mg/mL of USP Benzocaine RS in Diluent. Sonicate to dissolve, if necessary.

Sample solution: Nominally 0.1 mg/mL of benzocaine in Diluent prepared as follows. Transfer a portion of Gel, equivalent to 10 mg of benzocaine, into a 100-mL volumetric flask and dissolve it in Diluent. Pass through a suitable filter of 0.45-µm pore size, discarding the first 2-3 mL of filtrate.

Chromatographic system

(See Chromatography (621), System Suitability.)

Mode: LC

Detector: UV 280 nm. For Identification test A, use a diode array detector in the range of 200-400 nm.

Column: 4.6-mm × 25-cm; 5-µm packing L7

Flow rate: 1.5 mL/min

Injection volume: 20 µL

System suitability

Samples: System suitability solution and Standard solution

Suitability requirements

Resolution: NLT 10 between aminobenzoic acid and benzocaine, and between benzocaine and ethyl 4-nitrobenzoate, System suitability solution

Tailing factor: NMT 1.5, Standard solution

Relative standard deviation: NMT 1.0%, Standard solution

Analysis

Samples: Standard solution and Sample solution

Calculate the percentage of the labeled amount of benzocaine (C9H11NO2) in the portion of Gel taken:

Result = (rU/rS) × (CS/CU) × 100

r= peak response of benzocaine from the Sample solution

r= peak response of benzocaine from the Standard solution

CS = concentration of USP Benzocaine RS in the Standard solution (mg/mL)

CU = nominal concentration of benzocaine in the Sample solution (mg/mL)

Acceptance criteria: 90.0%-110.0%

4 PERFORMANCE TESTS

MINIMUM FILL (755): Meets the requirements

5 IMPURITIES

5.1 ORGANIC IMPURITIES

Solution A: 0.1% Trifluoroacetic acid, prepared by diluting 1.0 mL of trifluoroacetic acid with water to 1 L

Solution B: Acetonitrile

Mobile phase: See Table 1 in the Assay.

Diluent: Solution A and Solution B (1:1)

Standard solution: 1 µg/mL of USP Benzocaine RS and 2 µg/mL each of USP Aminobenzoic Acid RS and USP Ethyl 4-nitrobenzoate RS in

Diluent

Sample solution: Nominally 1 mg/mL of benzocaine in Diluent prepared as follows. Transfer a portion of Gel, equivalent to 50 mg of benzocaine, into a 50-mL volumetric flask, and dissolve in Diluent. Pass through a suitable filter of 0.45-µm pore size, discarding the first 2-3 mL of filtrate.

Chromatographic system

(See Chromatography (621), System Suitability.)

Mode: LC

Detector: UV 280 nm

Column: 4.6-mm × 25-cm; 5-µm packing L7

Flow rate: 1.5 mL/min

Injection volume: 20 µL

System suitability

Sample: Standard solution

Suitability requirements

Resolution: NLT 10 between aminobenzoic acid and benzocaine, and between benzocaine and ethyl 4-nitrobenzoate

Relative standard deviation: NMT 2.0% for each peak corresponding to benzocaine, aminobenzoic acid, and ethyl 4-nitrobenzoate

Analysis

Samples: Standard solution and Sample solution

Calculate the percentage of aminobenzoic acid and ethyl 4-nitrobenzoate in the portion of Gel taken:

Result = (rU/rS) × (CS/CU) × 100

r= peak response of aminobenzoic acid or ethyl 4-nitrobenzoate from the Sample solution

r= peak response of the corresponding Reference Standard from the Standard solution

CS = concentration of USP Aminobenzoic Acid RS or USP Ethyl 4-nitrobenzoate RS in the Standard solution (mg/mL)

CU = nominal concentration of benzocaine in the Sample solution (mg/mL)

Calculate the percentage of any other individual unspecified impurity in the portion of Gel taken:

Result = (rU/rS) × (CS/CU) × 100

r= peak response of any other individual unspecified impurity from the Sample solution

r= peak response of benzocaine from the Standard solution

CS = concentration of USP Benzocaine RS in the Standard solution (mg/mL)

CU = nominal concentration of benzocaine in the Sample solution (mg/mL)

Acceptance criteria: See Table 2. Disregard peaks less than 0.05%.

Table 2

NameRetention TimeCriteria, NMT (%)
Aminobenzoic acid0.290.20
Benzocaine1.0-
Ethyl 4-nitrobenzoate2.10.20
Any other individual unspecified impurity-0.10
Total impurities-1.0

6 SPECIFIC TESTS

MICROBIAL ENUMERATION TESTS (61) and TESTS FOR SPECIFIED MICROORGANISMS (62): It meets the requirements of the tests for absence of

Staphylococcus aureus and Pseudomonas aeruginosa.

7 ADDITIONAL REQUIREMENTS

PACKAGING AND STORAGE: Preserve in well-closed containers.

USP REFERENCE STANDARDS (11)

USP Aminobenzoic Acid RS

Benzoic acid, 4-amino.

C7H7NO2  137.14

USP Benzocaine RS

USP Ethyl 4-nitrobenzoate RS

Benzoic acid, 4-nitro-, ethyl ester.

C9H9NO4  195.17

vui lòng chờ tin đang tải lên

Vui lòng đợi xử lý......

0 SẢN PHẨM
ĐANG MUA
hotline
0927.42.6789